Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
RPID
Strong SellSinkerRapid Micro Biosystems, Inc. · Healthcare · United States · $79M · Avg Vol: $262K/d
COMPANY DESCRIPTION
Rapid Micro Biosystems, Inc. develops and sells automated microbial detection systems, primarily for quality control applications within the pharmaceutical industry. Its flagship Growth Direct® System offers a significant competitive advantage by accelerating microbial enumeration and detection, reducing manual labor and time-to-result. This positions the company as a key innovator in pharmaceutical quality control and manufacturing efficiency.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23.2M | 17.1M | 22.5M | 28.1M | 33.6M | 9.7% | 35.2M | 39.3M | 46.5M | 17.7% |
| EPS | -3.94 | -1.43 | -1.22 | -1.08 | -1.05 | — | -1.11 | -0.94 | -0.73 | — |
| Shares | 42.1M | 42.1M | 42.4M | 43.0M | 44.5M | +5.7% | 45.7M | — | — | — |
| Debt | 8.0M | 8.0M | 7.3M | 6.2M | 23.9M | 31.6% | 23.5M | — | — | — |
| Equity | 164.2M | 164.2M | 118.0M | 75.4M | 33.2M | -32.9% | — | — | — | — |
| Op CF | -55.0M | -58.5M | -45.1M | -44.2M | -31.1M | — | -40.1M | — | — | — |
| Inv CF | -13.3M | -93.5M | 42.2M | 36.7M | 14.3M | — | — | — | — | — |
| Fin CF | 216.7M | 0.7M | 0.1M | 0.2M | 19.8M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of RPID are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| RPID | Rapid Micro Biosystems, Inc.(you) | $79M | 6 | Strong Sell |
| CVRX | CVRx, Inc. | $79M | 9 | Strong Sell |
| MBOT | Microbot Medical Inc. | $99M | 7 | Strong Sell |
| LDX.AX | Lumos Diagnostics Holdings Limited | $68M | 3 | Strong Sell |
| HYPR | Hyperfine, Inc. | $88M | 12 | Strong Sell |
| SERA | Sera Prognostics, Inc. | $82M | 14 | Strong Sell |
| COCH | Envoy Medical, Inc. | $53M | 10 | Strong Sell |
| EBR.AX | EBR Systems, Inc. | $148M | 5 | Strong Sell |
| MDAI | Spectral AI, Inc. | $51M | 12 | Strong Sell |
| ELUT | Elutia Inc. | $51M | 13 | Strong Sell |
Peer medians: ROE -30.5% · P/E 27.0x · Gross margin 58.3%